(December 19, 2017, 11:55 AM EST) -- WASHINGTON, D.C. — A Delaware federal judge did not err in deeming a three-step method for stimulating and harvesting stem cells non-obvious, the Federal Circuit U.S. Court of Appeals ruled Dec. 18 in a win for Genzyme Corp. and Sanofi-Aventis U.S. LLC (Genzyme, collectively) (Genzyme Corporation, et al. v. Dr. Reddy’s Laboratories Ltd., et al., No. 16-2206, Fed. Cir., 2017 U.S. App. LEXIS 25454)....